DUBLIN--(BUSINESS WIRE)--The "Tumor Ablation Market Size, Share & Trends Analysis Report By Treatment (Surgical, Laparoscopic), By Technology (Radiofrequency, Microwave, Cryoablation), By Application, And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.
Increasing demand for minimally invasive surgeries coupled with technological advancements in thermal ablation is anticipated to boost market growth.
In addition, rising per capita income is enabling people to opt for advanced treatment for tumors. This factor is anticipated to positively influence market growth over the forecast period. Active role of healthcare agencies and government in creating awareness about various cancer types is expected to facilitate usage of tumor ablation therapy.
Further key findings from the study suggest:
- Radiofrequency emerged as the dominant technology segment with 30.5% share in 2016 attributed to application in removal of solid tumors
- Percutaneous procedures are expected to witness lucrative growth over the forecast period due to rising demand for minimally invasive procedures offering faster recovery and higher safety
- Lung cancer is anticipated to witness substantial growth owing to high prevalence caused by sedentary lifestyle, rise in smoking, and air pollution
Topics Covered
Chapter 1 Executive Summary
Chapter 2 Research Methodology
Chapter 3 Market Variables, Trends & Scope
Chapter 4 Tumor Ablation Market: Technology Estimates & Trend Analysis
Chapter 5 Tumor Ablation Market: Treatment Estimates & Trend Analysis
Chapter 6 Tumor Ablation Market: Application Estimates & Trend Analysis
Chapter 7 Market Share Analysis
Chapter 8 Regional Estimates & Trend Analysis, by Technology, Treatment, & Application
- Medtronic
- AngioDynamics
- Mermaid Medical
- HealthTronics Inc.
- Galil Medical Inc.
- EDAP TMS
- Boston Scientific Corporation
- SonaCare Medical LLC
- Misonix
- NeuWave Medical Inc.
- ERBE Elektromedizin GmbH
- Biotronik
For more information about this report visit https://www.researchandmarkets.com/research/khkz3q/global_tumor?w=4